70163-0029 NDC - TREE POLLEN (ACER NEGUNDO, ACER RUBRUM, ADRENALINUM, ALLIUM CEPA, ARSENICUM IODATUM, BETULA NIGRA, EUPHRASIA OFFICINALIS, FRAXINUS AMERICANA, HISTAMINUM HYDROCHLORICUM, LIGUSTRUM VULGARE, LIQUIDAMBAR STYRACIFLUA, MORUS ALBA, PINUS STROBUS, POPULUS DELTOIDES, QUERCUS RUBRA, SABADILLA, SALIX NIGRA, SANGUINARIA CANADENSIS)

Drug Information

  • Product NDC: 70163-0029
  • Proprietary Name: Tree Pollen
  • Non Proprietary Name: Acer Negundo, Acer Rubrum, Adrenalinum, Allium Cepa, Arsenicum Iodatum, Betula Nigra, Euphrasia Officinalis, Fraxinus Americana, Histaminum Hydrochloricum, Ligustrum Vulgare, Liquidambar Styraciflua, Morus Alba, Pinus Strobus, Populus Deltoides, Quercus Rubra, Sabadilla, Salix Nigra, Sanguinaria Canadensis
  • Active Ingredient(s): 12 [hp_X]/mL ACER NEGUNDO POLLEN; 12 [hp_X]/mL ACER RUBRUM POLLEN; 6 [hp_X]/mL ARSENIC TRIIODIDE; 12 [hp_X]/mL BETULA NIGRA POLLEN; 6 [hp_X]/mL EPINEPHRINE; 6 [hp_X]/mL EUPHRASIA STRICTA; 12 [hp_X]/mL FRAXINUS AMERICANA POLLEN; 12 [hp_X]/mL HISTAMINE DIHYDROCHLORIDE; 12 [hp_X]/mL LIGUSTRUM VULGARE POLLEN; 12 [hp_X]/mL LIQUIDAMBAR STYRACIFLUA POLLEN; 12 [hp_X]/mL MORUS ALBA POLLEN; 6 [hp_X]/mL ONION; 12 [hp_X]/mL PINUS STROBUS POLLEN; 12 [hp_X]/mL POPULUS DELTOIDES POLLEN; 12 [hp_X]/mL QUERCUS RUBRA POLLEN; 12 [hp_X]/mL SALIX NIGRA POLLEN; 6 [hp_X]/mL SANGUINARIA CANADENSIS ROOT; 6 [hp_X]/mL SCHOENOCAULON OFFICINALE SEED
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Vegetable Proteins [CS]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Labeler Information

Field Name Field Value
Labeler Name: NaturalCare
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:3/4/2026

Package Information

No. Package Code Package Description Billing Unit
170163-0029-21 BOTTLE, DROPPER in 1 CARTON (70163-0029-2) / 30 mL in 1 BOTTLE, DROPPER (70163-0029-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC70163-0029The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMETree PollenThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAcer Negundo, Acer Rubrum, Adrenalinum, Allium Cepa, Arsenicum Iodatum, Betula Nigra, Euphrasia Officinalis, Fraxinus Americana, Histaminum Hydrochloricum, Ligustrum Vulgare, Liquidambar Styraciflua, Morus Alba, Pinus Strobus, Populus Deltoides, Quercus Rubra, Sabadilla, Salix Nigra, Sanguinaria CanadensisThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE3/4/2026This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENaturalCareName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACER NEGUNDO POLLEN; ACER RUBRUM POLLEN; ARSENIC TRIIODIDE; BETULA NIGRA POLLEN; EPINEPHRINE; EUPHRASIA STRICTA; FRAXINUS AMERICANA POLLEN; HISTAMINE DIHYDROCHLORIDE; LIGUSTRUM VULGARE POLLEN; LIQUIDAMBAR STYRACIFLUA POLLEN; MORUS ALBA POLLEN; ONION; PINUS STROBUS POLLEN; POPULUS DELTOIDES POLLEN; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; SANGUINARIA CANADENSIS ROOT; SCHOENOCAULON OFFICINALE SEEDAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH12; 12; 6; 12; 6; 6; 12; 12; 12; 12; 12; 6; 12; 12; 12; 12; 6; 6 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 3/6/2026

Previous Code
Next Code